Biogen Europe

Biogen Europe is owned by Biogen.

Biogen is one of the...

• Forbes Global 2000 (#706);
• Fortune 500 (#338);
• Nasdaq 100;
• Russell 3000;
• S&P 500.

Biogen is a company listed under the stock ticker BIIB (US).

Biogen has a direct presence in 9 countries.

Biogen has 9 subsidiaries including Biogen ANZ, Biogen BeLux and Biogen Canada.

They are in:

• Biotechnology90%
• Medical Equipment10%

View the org chart displaying its 35 main executives

Most searched biographies at Biogen Europe

• Katja Buller, Vice President and Head of Corporate Affairs Interna...
• Peter Puype, Global Head of Supply Chain
• David Nestor, Head of Neuromuscular Disease

Create an alert
to follow the executive moves at Biogen Europe.

Biogen has 2,097 competitors including Neptune Wellness Solutions (Canada), Bonesupport (Sweden) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Cellaritybio has just announced a $121 Million fundraising. (posted on October 7 2022).
• Pfizer has acquired Global Blood Therapeutics (posted on October 6 2022).
• Ventus Therapeutics has just announced a $70 Million fundraising. (posted on October 5 2022).

Popular contacts in Biotechnology

• Jan Hellqvist - Director at Inhalation Sciences
• Håkan Garpenstrand - Head of Business Development at Immedica Pharma
• Neal Mohan - Director at 23andMe

Learn more about the Biotechnology industry >

Press releases by Biogen Europe

Social media about Biogen Europe

• Biogen Europe on Wikipedia, Google News & Yahoo Finance
• Biogen Europe on LinkedIn, Twitter & YouTube

Contact by email its executives including Peter Puype

Call Biogen Europe at +41 41...

View the org chart

Register to receive your alert

Report an error